---
title: "Inositol Niacinate - Hypoalphalipoproteinemia"
sidebar: mydoc_sidebar
permalink: inositolniacinatehypoalphalipoproteinemia.html
toc: false 
---

{% include image.html url="images/inositolniacinatehypoalphalipoproteinemia.png" file="inositolniacinatehypoalphalipoproteinemia.png" alt="inositolniacinatehypoalphalipoproteinemia" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C005193 | Inositol Niacinate | Drug |
| UniProt:P49019 | Hydroxycarboxylic acid receptor 3 | Protein |
| UniProt:Q8TDS4 | Hydroxycarboxylic acid receptor 2 | Protein |
| REACT:R-HSA-418594 | G alpha (i) signalling events | Pathway |
| GO:0016042 | lipid catabolic process | BiologicalProcess |
| MESH:D014280 | Triglycerides | ChemicalSubstance |
| MESH:D008075 | Lipoproteins, HDL | ChemicalSubstance |
| MESH:D052456 | Hypoalphalipoproteinemia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Inositol Niacinate | INCREASES ACTIVITY OF | Hydroxycarboxylic Acid Receptor 3 |
| Inositol Niacinate | INCREASES ACTIVITY OF | Hydroxycarboxylic Acid Receptor 2 |
| Hydroxycarboxylic Acid Receptor 3 | PARTICIPATES IN | G Alpha (I) Signalling Events |
| Hydroxycarboxylic Acid Receptor 2 | PARTICIPATES IN | G Alpha (I) Signalling Events |
| G Alpha (I) Signalling Events | NEGATIVELY REGULATES | Lipid Catabolic Process |
| Lipid Catabolic Process | DECREASES ABUNDANCE OF | Triglycerides |
| Triglycerides | NEGATIVELY CORRELATED WITH | Lipoproteins, Hdl |
| Lipoproteins, Hdl | NEGATIVELY CORRELATED WITH | Hypoalphalipoproteinemia |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB08949#mechanism-of-action](https://go.drugbank.com/drugs/DB08949#mechanism-of-action){:target="_blank"}